212 related articles for article (PubMed ID: 31341644)
1. Dysregulated calcium homeostasis prevents plasma membrane repair in Anoctamin 5/TMEM16E-deficient patient muscle cells.
Chandra G; Defour A; Mamchoui K; Pandey K; Mishra S; Mouly V; Sreetama S; Mahad Ahmad M; Mahjneh I; Morizono H; Pattabiraman N; Menon AK; Jaiswal JK
Cell Death Discov; 2019; 5():118. PubMed ID: 31341644
[TBL] [Abstract][Full Text] [Related]
2. Deficiency of Anoctamin 5/TMEM16E causes nuclear positioning defect and impairs Ca
Phuong TTT; An J; Park SH; Kim A; Choi HB; Kang TM
Korean J Physiol Pharmacol; 2019 Nov; 23(6):539-547. PubMed ID: 31680776
[TBL] [Abstract][Full Text] [Related]
3. Coping with the calcium overload caused by cell injury: ER to the rescue.
Chandra G; Mázala DAG; Jaiswal JK
Cell Stress; 2021 Apr; 5(5):73-75. PubMed ID: 33987529
[TBL] [Abstract][Full Text] [Related]
4. Endoplasmic reticulum maintains ion homeostasis required for plasma membrane repair.
Chandra G; Sreetama SC; Mázala DAG; Charton K; VanderMeulen JH; Richard I; Jaiswal JK
J Cell Biol; 2021 May; 220(5):. PubMed ID: 33688936
[TBL] [Abstract][Full Text] [Related]
5. Anoctamin 5 Knockout Mouse Model Recapitulates LGMD2L Muscle Pathology and Offers Insight Into in vivo Functional Deficits.
Thiruvengadam G; Sreetama SC; Charton K; Hogarth M; Novak JS; Suel-Petat L; Chandra G; Allard B; Richard I; Jaiswal JK
J Neuromuscul Dis; 2021; 8(s2):S243-S255. PubMed ID: 34633328
[TBL] [Abstract][Full Text] [Related]
6. Recessive mutations in the putative calcium-activated chloride channel Anoctamin 5 cause proximal LGMD2L and distal MMD3 muscular dystrophies.
Bolduc V; Marlow G; Boycott KM; Saleki K; Inoue H; Kroon J; Itakura M; Robitaille Y; Parent L; Baas F; Mizuta K; Kamata N; Richard I; Linssen WH; Mahjneh I; de Visser M; Bashir R; Brais B
Am J Hum Genet; 2010 Feb; 86(2):213-21. PubMed ID: 20096397
[TBL] [Abstract][Full Text] [Related]
7. Genetic disruption of Ano5 in mice does not recapitulate human ANO5-deficient muscular dystrophy.
Xu J; El Refaey M; Xu L; Zhao L; Gao Y; Floyd K; Karaze T; Janssen PM; Han R
Skelet Muscle; 2015; 5():43. PubMed ID: 26693275
[TBL] [Abstract][Full Text] [Related]
8. Defective membrane fusion and repair in Anoctamin5-deficient muscular dystrophy.
Griffin DA; Johnson RW; Whitlock JM; Pozsgai ER; Heller KN; Grose WE; Arnold WD; Sahenk Z; Hartzell HC; Rodino-Klapac LR
Hum Mol Genet; 2016 May; 25(10):1900-1911. PubMed ID: 26911675
[TBL] [Abstract][Full Text] [Related]
9. A novel ANO5 splicing variant in a LGMD2L patient leads to production of a truncated aggregation-prone Ano5 peptide.
Xu J; Xu L; Lau YS; Gao Y; Moore SA; Han R
J Pathol Clin Res; 2018 Apr; 4(2):135-145. PubMed ID: 29665321
[TBL] [Abstract][Full Text] [Related]
10. Development of muscular dystrophy in a CRISPR-engineered mutant rabbit model with frame-disrupting ANO5 mutations.
Sui T; Xu L; Lau YS; Liu D; Liu T; Gao Y; Lai L; Han R; Li Z
Cell Death Dis; 2018 May; 9(6):609. PubMed ID: 29789544
[TBL] [Abstract][Full Text] [Related]
11. Anoctamin 5/TMEM16E facilitates muscle precursor cell fusion.
Whitlock JM; Yu K; Cui YY; Hartzell HC
J Gen Physiol; 2018 Nov; 150(11):1498-1509. PubMed ID: 30257928
[TBL] [Abstract][Full Text] [Related]
12. Anoctamin 5 (ANO5) Muscle Disorders: A Narrative Review.
Soontrapa P; Liewluck T
Genes (Basel); 2022 Sep; 13(10):. PubMed ID: 36292621
[TBL] [Abstract][Full Text] [Related]
13. Comparing clinical data and muscle imaging of DYSF and ANO5 related muscular dystrophies.
Ten Dam L; van der Kooi AJ; Rövekamp F; Linssen WH; de Visser M
Neuromuscul Disord; 2014 Dec; 24(12):1097-102. PubMed ID: 25176504
[TBL] [Abstract][Full Text] [Related]
14. Anoctamin 5 (ANO5) muscular dystrophy-three different phenotypes and a new histological pattern.
Seguí F; Gonzalez-Quereda L; Sanchez A; Matas-García A; Garrabou G; Rodriguez MJ; Gallano P; Grau JM; Milisenda JC
Neurol Sci; 2020 Oct; 41(10):2967-2971. PubMed ID: 32399949
[TBL] [Abstract][Full Text] [Related]
15. Anoctamin-5 Muscular Dystrophy: Report of Two Cases with Different Phenotypes and Genotypes from the Indian Subcontinent.
Mahajan S; Dhall A; Jassal B; Saluja A; Faruq M; Suri V; Rajan R; Vishnu VY; Sharma MC
Neurol India; 2022; 70(5):2169-2173. PubMed ID: 36352632
[TBL] [Abstract][Full Text] [Related]
16. [Muscular dystrophy due to mutations in anoctamin 5: clinical and molecular genetic findings].
Deschauer M; Joshi PR; Gläser D; Hanisch F; Stoltenburg G; Zierz S
Nervenarzt; 2011 Dec; 82(12):1596-603. PubMed ID: 21739273
[TBL] [Abstract][Full Text] [Related]
17. ANO5-muscular dystrophy: clinical, pathological and molecular findings.
Liewluck T; Winder TL; Dimberg EL; Crum BA; Heppelmann CJ; Wang Y; Bergen HR; Milone M
Eur J Neurol; 2013 Oct; 20(10):1383-9. PubMed ID: 23663589
[TBL] [Abstract][Full Text] [Related]
18. BVES is a novel interactor of ANO5 and regulates myoblast differentiation.
Li H; Xu L; Gao Y; Zuo Y; Yang Z; Zhao L; Chen Z; Guo S; Han R
Cell Biosci; 2021 Dec; 11(1):222. PubMed ID: 34963485
[TBL] [Abstract][Full Text] [Related]
19. ANO5 in membrane repair - Status: "It's complicated".
Gerke V; Rescher U
Cell Calcium; 2021 Apr; 97():102415. PubMed ID: 33934044
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
